KRUSHNA CHANDRA HEMBRAM

Employment

• Purdue University Postdoctoral Research Associate
  2023 - 2024
• Indian Institute of Technology Hyderabad Senior Technical Superintendent
  2019 - Present
• Institute of Microbial Technology CSIR JRF/SRF
  2014 - 2017

Education

• KIIT School of Biotechnology PhD
  2017 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Poly(lactic acid) (PLA) as drug and gene delivery system for tumor
  Cancer Therapy 2024 1 citation DOI: 10.1016/b978-0-443-15401-0.00007-5
  +Save
• Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics
  2024 7 citations DOI: 10.1016/bs.ircmb.2024.01.001
  +Save
• Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages
  Rajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram +3 more
  Journal of Nutritional Biochemistry 2021 85 citations DOI: 10.1016/j.jnutbio.2021.108624
  +Save
• PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO).
  Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla +2 more
  Cellular signalling 2020 50 citations DOI: 10.1016/j.cellsig.2020.109902
  +Save
• Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
  Krushna Chandra Hembram, Somya Ranjan Dash, Biswajit Das +4 more
  Molecular pharmaceutics 2020 23 citations DOI: 10.1021/acs.molpharmaceut.0c00197
  +Save
• Erratum: Comparative and mechanistic study on the anticancer activity of quinacrine-based silver and gold hybrid nanoparticles in head and neck cancer (Molecular Pharmaceutics (2019) 16:7 (3011-3023) DOI: 10.1021/acs.molpharmaceut.9b00242)
  Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy +5 more
  Molecular Pharmaceutics 2020 1 citation DOI: 10.1021/acs.molpharmaceut.0c00716
  +Save
• PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade.
  Sefinew Molla, Krushna Chandra Hembram, Subhajit Chatterjee +4 more
  Pathology oncology research : POR 2019 31 citations DOI: 10.1007/s12253-019-00768-0
  +Save
• Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer.
  Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy +5 more
  Molecular pharmaceutics 2019 25 citations DOI: 10.1021/acs.molpharmaceut.9b00242
  +Save
• Expression of an endo α-1, 3-Glucanase gene from Trichoderma harzianum in rice induces resistance against sheath blight
  Journal of Plant Biochemistry and Biotechnology 2019 DOI: https://doi.org/10.1007/s13562-018-0465-7
  +Save
• Therapeutic prospective of plant-induced silver nanoparticles: application as antimicrobial and anticancer agent.
  Krushna Chandra Hembram, Rahul Kumar, Laxman Kandha +3 more
  Artificial cells, nanomedicine, and biotechnology 2018 158 citations DOI: 10.1080/21691401.2018.1489262
  +Save
• Advances in preparation and characterization of chitosan nanoparticles for therapeutics.
  Artificial cells, nanomedicine, and biotechnology 2014 145 citations DOI: 10.3109/21691401.2014.948548
  +Save